Akebia Therapeutics (AKBA) Treasury Shares (2013 - 2026)

Akebia Therapeutics (AKBA) has 3 years of Treasury Shares data on file, last reported at $162000.0 in Q1 2016.

• On a quarterly basis, Treasury Shares rose 0.62% year-over-year to $162000.0 in Q1 2016; TTM through Mar 2016 was $162000.0, a 0.62% increase from a year earlier, with the FY2015 full-year figure at $162000.0, up 72.34% from the prior year.
• Treasury Shares for Q1 2016 stood at $162000.0, roughly flat from $162000.0 in the prior quarter.
• Over the last five years, Treasury Shares for AKBA reached as high as $9.1 million in Q1 2026 and fell as low as $330622.0 in Q4 2025.
• Historically, Treasury Shares has averaged $3.8 million across 5 years, with a median of $3.3 million in 2023.
• Across the five-year window, Treasury Shares soared 658.36% in 2015 and advanced 0.62% in 2016, its largest moves.
• Year by year, Treasury Shares stood at $94000.0 in 2014, then soared by 72.34% to $162000.0 in 2015, then changed by 0.0% to $162000.0 in 2016.
• Per Business Quant data, the three most recent Treasury Shares figures were $162000.0 in Q1 2016, $162000.0 in Q4 2015, and $162000.0 in Q3 2015.